Canadian Cancer Society's CIBC Run for the Cure Marks 35 Years with $67.6M Raised, Advocates for Earlier Breast Cancer Screening
Event summary
- 35th annual CIBC Run for the Cure scheduled for October 4, 2026, across 50+ Canadian communities
- CIBC has raised $67.6M since becoming title partner in 1997
- 5-year breast cancer survival rate reaches 90% for women, death rate halved since early 1990s
- CCS advocates for lowering breast screening start age to 40 for average-risk individuals
- 2026 estimates: 32,400 women and 300 men diagnosed, 5,460 deaths expected
The big picture
The CIBC Run for the Cure represents a sustained national effort to combat breast cancer through research funding and advocacy. With CIBC's 30-year partnership and CCS's push for earlier screening, the event highlights the intersection of corporate social responsibility and public health innovation. The 90% survival rate milestone underscores the long-term impact of collective action in cancer research.
What we're watching
- Advocacy Impact
- Whether CCS's push to lower breast screening age to 40 will gain provincial/territorial support
- Fundraising Momentum
- The pace at which CIBC Run for the Cure maintains or grows its $67.6M fundraising legacy
- Research Breakthroughs
- How AI, genomic testing, and 3D bioprinting advancements will translate into clinical outcomes